Public Law 119-95 (05/29/2026)

Part E General Provisions Relating to Drugs and Devices

Browse 0 units and 21 sections in Part E General Provisions Relating to Drugs and Devices of Title 21.

Sections in Part E

§ 360bbb Expanded access to unapproved therapies and diagnostics § 360bbb–0 Expanded access policy required for investigational drugs § 360bbb–0a Investigational drugs for use by eligible patients § 360bbb–1 Dispute resolution § 360bbb–2 Classification of products § 360bbb–3 Authorization for medical products for use in emergencies § 360bbb–3a Emergency use of medical products § 360bbb–3b Products held for emergency use § 360bbb–3c Expedited development and review of medical products for emergency uses § 360bbb–4 Countermeasure development, review, and technical assistance § 360bbb–4a Priority review to encourage treatments for agents that present national security threats § 360bbb–4b Medical countermeasure master files § 360bbb–5 Critical Path Public-Private Partnerships § 360bbb–5a Emerging technology program § 360bbb–6 Risk communication § 360bbb–7 Notification § 360bbb–8 Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments § 360bbb–8a Optimizing global clinical trials § 360bbb–8b Use of clinical investigation data from outside the United States § 360bbb–8c Patient participation in medical product discussion § 360bbb–8d Notification, nondistribution, and recall of controlled substances